UCB announces US and EU regulatory filings for brivaracetam
UCB announced regulatory milestones in the US and the EU for its investigational antiepileptic drug brivaracetam.
UCB announced regulatory milestones in the US and the EU for its investigational antiepileptic drug brivaracetam.